Lemonade, Inc. Files 8-K: Board Changes & Officer Compensation

Ticker: LMND · Form: 8-K · Filed: Oct 15, 2025 · CIK: 1691421

Lemonade, INC. 8-K Filing Summary
FieldDetail
CompanyLemonade, INC. (LMND)
Form Type8-K
Filed DateOct 15, 2025
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$0.00001, $30,000, $175,000, $150,000
Sentimentneutral

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

Related Tickers: LMND

TL;DR

Lemonade's board is shuffling, and exec pay is changing. Keep an eye on this.

AI Summary

On October 15, 2025, Lemonade, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates a departure of directors and the election of new ones, alongside updates to compensatory arrangements for certain officers. Specific details regarding the individuals involved and the financial implications of these compensation changes are expected to be elaborated within the full report.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future financial performance, impacting investor confidence.

Risk Assessment

Risk Level: medium — Changes in board and executive compensation can introduce uncertainty and signal potential strategic shifts or governance issues.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates the departure of directors and the election of new directors, though specific names are not detailed in this summary.

What is the nature of the changes to compensatory arrangements?

The filing states there are updates to the compensatory arrangements of certain officers, but the specifics are not provided in this summary.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on October 15, 2025.

What is Lemonade, Inc.'s state of incorporation?

Lemonade, Inc. is incorporated in Delaware.

What is Lemonade, Inc.'s principal executive office address?

The principal executive offices are located at 5 Crosby Street, 3rd Floor, New York, NY 10013.

Filing Stats: 649 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2025-10-15 16:31:39

Key Financial Figures

Filing Documents

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 15, 2025, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, appointed Mr. Prashant Ratanchandani to the Board effective October 15, 2025. Mr. Ratanchandani will serve as a Class II director for a term expiring at the Company's annual meeting of stockholders to be held in 2028, until his successor is duly elected and qualified or his earlier death, disqualification, resignation or removal. Mr. Ratanchandani is eligible to participate in the Company's Non-Employee Director Compensation Policy, which provides for: (i) an annual cash retainer of $30,000 for serving on the Board, earned on a quarterly basis; (ii) an initial equity-based award of restricted stock units (the "Initial Award") in an amount equal to $175,000 that vests in equal annual installments over three years following the grant date, subject to his continued service on the Board through each such vesting date; and (iii) following each annual meeting of the Company's stockholders, an annual equity-based award of restricted stock units in an amount of $150,000 that vests on the first anniversary of the date of grant, subject to his continued service on the Board through such vesting date. Mr. Ratanchandani has entered into the Company's standard indemnification agreement for directors and officers. There is no arrangement or understanding pursuant to which Mr. Ratanchandani was appointed to the Board. There are no family relationships between Mr. Ratanchandani and any director or executive officer of the Company as defined in Item 401(d) of Regulation S-K, and Mr. Ratanchandani has no direct or indirect material interest in any transaction or proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LEMONADE, INC. Date: October 15, 2025 By: /s/ Tim Bixby Tim Bixby Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing